StockData
MiniMed Group, Inc. logo

MiniMed Group, Inc. (MMED) stock

MMEDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 8, 2026Score 13/3050% below fair value
$17.78−0.87 (-4.66%)

Close on Nov 17, 2026Market cap $5.00BP/E –Yield –

Earnings

MiniMed's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue, Q1 FY2027
$843.00M
EPS, Q1 FY2027
–
Latest guidance
Raised
Sep 1, 2026 · 2 items

Quarterly results

Revenue and earnings per share from each of MiniMed's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q1 FY2027ended Jul 31, 2026Sep 1, 2026before the open$843.00M––Release
Q4 FY2026ended Apr 24, 2026Jun 3, 2026before the open$837.00M–-$0.68Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

MiniMed's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
Organic revenue growthnon-GAAPFY2027+10.5%+10%RaisedSep 1, 2026
Adjusted EBITDA marginnon-GAAPFY202716%–NewSep 1, 2026
Adjusted EBITDA marginnon-GAAPFY202716%–NewJun 3, 2026

Guidance history

Every forecast MiniMed put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Sep 1, 2026Adjusted EBITDA marginFY202716%New
Sep 1, 2026Organic revenue growthFY2027+10.5%Raised
Jun 3, 2026Adjusted EBITDA marginFY202716%New
Jun 3, 2026Organic revenue growthFY2027+10%New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases MiniMed filed with the SEC as exhibits to Form 8-K or 6-K

See a number that looks wrong?